Loading…

Association Between Genetic Polymorphism in DNA Repair Genes and Acute Myeloid Leukemia

Abstract 4131 Genetic variants in DNA repair genes may affect DNA repair capacity and modulate cancer susceptibility. We analyzed genetic polymorphisms of 11 DNA repair genes: XRCC4, BRCA1, WRN, RAD51, XRCC3, ERCC1, ERCC2, XPC, OGG1, XRCC1 and MGMT to evaluate the association and risk of acute myelo...

Full description

Saved in:
Bibliographic Details
Published in:Blood 2009-11, Vol.114 (22), p.4131-4131
Main Authors: Kim, Hee Nam, Kim, Nan young, Yu, Li, Tran, Huong Thi Thanh, Kim, Yeo-Kyeoung, Lee, Il-Kwon, Yang, Deok-Hwan, Lee, Je-Jung, Kim, Hee-Je, Min, Woo-Sung, Park, Moo-Rim, Jo, Deog Yeon, Won, Jong Ho, Kwak, Jae-Yong, Kim, Hyeoung-Joon
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract 4131 Genetic variants in DNA repair genes may affect DNA repair capacity and modulate cancer susceptibility. We analyzed genetic polymorphisms of 11 DNA repair genes: XRCC4, BRCA1, WRN, RAD51, XRCC3, ERCC1, ERCC2, XPC, OGG1, XRCC1 and MGMT to evaluate the association and risk of acute myeloid leukemia (AML). A large-scale population-based, case-control study of 1700 controls and 659 cases was conducted in Chonnam National University Hwasun Hospital, Korea. Three single-nucleotide polymorphisms(SNPs), ERCC1 IVS5 +33 CC, WRN 787 GG and XRCC1 399 GA genotypes were associated with decreased risk for AML [odds ratio (OR) = 0.71; 95% confidence interval (CI) = 0.54-0.92, p=0.01 for IVS5 +33 CC, 0.67; 0.50–0.89, p=0.006 for 3149 GG and 0.81; 0.67–0.98, p=0.031 for 1316 GA]. We found no differences in the XRCC4 S307, BRCA1 P87L, RAD51 –G135C, XRCC3 T241M, ERCC2 K751Q, XPC K939Q, OGG1 S326C and MGMT L84F genotypes. Our results suggest that these 3 SNPs in DNA repair genes may affect AML susceptibility by modulating activities to maintain the genome integrity of each individual. No relevant conflicts of interest to declare.
ISSN:0006-4971
1528-0020
DOI:10.1182/blood.V114.22.4131.4131